Market Overview - On May 13, Hong Kong's three major indices collectively declined, with the Hang Seng Index falling by 1.87%, the Hang Seng China Enterprises Index down by 2.02%, and the Hang Seng Tech Index decreasing by 3.26% [1] Sector Performance - The Apple-related stocks experienced significant declines, including: - Highway Electronics (01415.HK) down 7.69% - Sunny Optical Technology (02382.HK) down 7.64% - BYD Electronics (00285.HK) down 7.11% - AAC Technologies (02018.HK) down 3.07% - Q Tech (01478.HK) down 3.41% [1] - The automotive supply chain, including lithium batteries and Tesla-related stocks, also saw declines: - Jinli Permanent Magnet (06680.HK) down 4.88% - Xpeng Motors-W (09868.HK) down 5.35% - NIO-SW (09866.HK) down 5.17% - Xiaomi Group-W (01810.HK) down 3.85% - Li Auto-W (02015.HK) down 3.05% [1] - Semiconductor stocks faced notable declines: - Hua Hong Semiconductor (01347.HK) down 4.24% - SMIC (00981.HK) down 4.05% - Beike Micro (02149.HK) down 2.86% - Shanghai Fudan (01385.HK) also declined [1] Technology Sector - Technology-related stocks, including short video concepts, cloud office, and cloud computing, mostly weakened: - Weimob Group (02013.HK) down 5.52% - Kuaishou-W (01024.HK) down 4.62% - Bilibili-W (09626.HK) down 3.14% - Alibaba-W (09988.HK) down 3.89% - NetEase-S (09999.HK) down 2.96% - Kingsoft Cloud (03896.HK) down 5.91% [2] - Other consumer sectors, including holiday concepts, sports goods, home appliances, and beer, also saw declines: - Meituan-W (03690.HK) down 4.91% - China Resources Beer (00291.HK) down 4.63% - Hisense Home Appliances (00921.HK) down 2.33% [2] Biopharmaceutical Sector - The biopharmaceutical and medical aesthetics sectors showed resilience, with notable gains: - Kintor Pharmaceutical-B (02171.HK) up 14.94% - Peijia Medical-B (09996.HK) up 9.2% - Yiming Oncology-B (01541.HK) up 7.77% - Genscript Biotech (02367.HK) up 5.64% [2] Gold Sector - The gold sector saw gains in the afternoon, with significant increases: - Tongguan Gold (00340.HK) up 15.79% - Chifeng Jilong Gold Mining (06693.HK) up 5.19% - Lingbao Gold (03330.HK) up 5.37% - Shandong Gold (01787.HK) up 4.75% - China Gold International (02099.HK) up 4.26% - Zhaojin Mining (01818.HK) up 3.45% [3] - The international gold price rebounded, influenced by uncertainties in U.S. macroeconomic policies and inflation concerns, which may support gold prices throughout the year [3]

Group 1: Market Reaction to US-China Trade Talks - The joint statement from the US-China Geneva trade talks led to a significant rise in Hong Kong's stock indices, with the Hang Seng Index increasing by 2.98%, the Hang Seng China Enterprises Index rising by 3.01%, and the Hang Seng Tech Index surging by 5.16% [1] Group 2: Performance of Apple-Related Stocks - Apple-related stocks saw substantial gains, with notable increases such as Highway Electronics up 18.45%, AAC Technologies up 15.37%, Sunny Optical Technology up 14.83%, and Q Tech up 13.45% [1] Group 3: Apple Price Cuts and Future Strategy - Apple announced price cuts for the iPhone 16 Pro Max by $160 and the iPhone 16 Pro by $176, with a shift in its iPhone release strategy starting in 2026, introducing base models in the first half and Pro, ultra-thin, and foldable models in the second half [1] Group 4: Technology Sector Performance - Technology-related stocks, including short video, cloud computing, and gaming sectors, experienced gains, with companies like Weimob up 7.74%, Bilibili up 6.63%, and JD.com up 6.39% [2] Group 5: Brokerage Stocks Surge - Chinese brokerage stocks saw collective gains, with Hongye Futures up 14.44%, CICC up 7.24%, and China Galaxy up 6.73%, attributed to recent interest rate cuts that enhance market liquidity [2] Group 6: Port Transportation and Automotive Stocks - Port transportation stocks performed well, with COSCO Shipping Holdings up 8.52% and COSCO Shipping Energy up 4.34%. Additionally, electric vehicle stocks like BYD Electronics rose by 13.79% and Xpeng Motors by 10.64% [3] Group 7: Decline in Biopharmaceutical and Gold Stocks - Biopharmaceutical stocks fell, with BeiGene down 8.97% and Zai Lab down 5.51%, influenced by US policy changes aimed at reducing drug prices. Gold stocks also declined, with Lingbao Gold down 11.23% following a drop in spot gold prices [4]

Group 1 - The overall market continues to shrink, with total trading volume down 8.26% to 1.1543 trillion, marking a new low since the Spring Festival [1] - Micro-cap stocks rebounded over 2%, but the market remains chaotic with 74 stocks hitting the daily limit up and nearly 3,500 stocks rising overall [1] - The robotics sector showed strong recovery, particularly in machine tools, while marine economy stocks, especially in the cable sector, performed relatively well [1][3] Group 2 - Morgan Stanley upgraded the rating of the Chinese stock market to "neutral," predicting an 8% increase in the market this year, with the Hang Seng Index expected to reach 25,000 points [4] - The recovery in corporate return on equity (ROE) and valuation is driven by enhanced corporate self-discipline, improved shareholder returns, and a shift towards higher-quality, less macro-sensitive industries [4] Group 3 - Recent market declines are attributed to performance pressure in March-April, multiple stocks facing direct ST (special treatment), and concerns over capital expenditures from Tencent and telecom operators [5] - The upcoming April 2 tariff implementation and the acceleration of company earnings reports by the end of April are critical upcoming events that may impact market sentiment [5] Group 4 - The chemical sector continues to strengthen with price increases, and stocks like Zhongyida and Jiangtian Chemical have shown significant gains [3] - The robotics sector has potential catalysts and layout opportunities, with stocks like Nanfang Precision and Linzhou Heavy Machinery reaching new highs [2][3]